Skip to content

Lithium Clearance in Patients With High Risk of Acute Kidney Injury

Proximal Tubule Function in Septic Patients as Measured by Endogenous Lithium Clearance

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05648435
Enrollment
21
Registered
2022-12-13
Start date
2022-12-07
Completion date
2023-01-31
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Brief summary

Renal lithium clearance is hypothesized to be a useful indicator of renal tubular function. In this study lithium clearance will be monitored in patients with sepsis associated acute kidney injury and in healthy controls.

Detailed description

Lithium is almost completely reabsorbed in the proximal tubule in parallel with sodium and water. What is not reabsorbed here is assumed to be fully excreted in urine, giving a reasonably accurate measurement of sodium reabsorption in the proximal tubule. Endogenous lithium clearance will be measured by inductively coupled plasma mass spectrometry (ICP-MS). The Gomez equations will be applied to calculate efferent arteriolar resistance, afferent arteriolar resistance, glomerular hydrostatic pressure, glomerular filtration pressure, and glomerular oncotic pressure. N-acetyl-β-D glucosaminidase (NAG) and NGAL, markers of tubular injury, will be measured by a spectrophotometric method using a commercially available kit. Routine blood and urine analyses will be performed at the Diagnostic Clinic Laboratory, University Hospital of North Norway, Tromsø.

Interventions

DIAGNOSTIC_TESTLithium measures

Measurements of lithium levels in blood and urine

Sponsors

University Hospital of North Norway
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

sepsis associated acute kidney injury: * Sepsis diagnosed or suspected * Age \>18 years Inclusion Criteria healthy controls: * Previously healthy individuals * Age \>18 years

Exclusion criteria

Oliguria or renal impairment due to other causes than sepsis. Pregnancy or breast-feeding.

Design outcomes

Primary

MeasureTime frameDescription
Renal lithium clearanceRepeated measures between 07:00-20:00Measurement of renal lithium clearance at 8AM, 2 PM, and 8 PM

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026